Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
APEN
|
Neil Gagnon
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 378 Added 1.67% |
$1,796
$4.75 p/Share
|
Feb 18
2021 |
APEN
|
Neil Gagnon
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,649 Added 0.43% |
$7,833
$4.75 p/Share
|
Feb 18
2021 |
EFSI
|
James R Wilkins Jr
Director |
BUY
Open market or private purchase
|
Direct | 35 Added 0.02% |
$1,015
$29.0 p/Share
|
Feb 18
2021 |
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 209 Added 0.19% |
$3,131
$14.98 p/Share
|
Feb 18
2021 |
COFS
|
David Bush
Director |
BUY
Open market or private purchase
|
Indirect | 944 Added 4.84% |
$24,506
$25.96 p/Share
|
Feb 18
2021 |
COFS
|
David Bush
Director |
BUY
Open market or private purchase
|
Direct | 820 Added 0.75% |
$21,287
$25.96 p/Share
|
Feb 18
2021 |
DFCO
|
Brian Bonar
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 2,500 Added 0.05% |
$1,125
$0.45 p/Share
|
Feb 18
2021 |
ONTF
|
Goldman Sachs Group Inc |
BUY
Open market or private purchase
|
Indirect | 100 Added 0.0% |
$6,506
$65.06 p/Share
|
Feb 18
2021 |
DSE
|
Css LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 11,881 Added 3.62% |
$81,266
$6.84 p/Share
|
Feb 18
2021 |
PRTA
|
Eco R1 Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 198,840 Added 1.94% |
$4,664,786
$23.46 p/Share
|
Feb 17
2021 |
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 257 Added 0.23% |
$3,870
$15.06 p/Share
|
Feb 17
2021 |
FRST
|
Matthew Alan Switzer
EVP, CFO |
BUY
Open market or private purchase
|
Direct | 30,000 Added 34.09% |
$387,000
$12.9 p/Share
|
Feb 17
2021 |
CVS
|
Edward J Ludwig
Director |
BUY
Open market or private purchase
|
Direct | 3,000 Added 17.31% |
$216,000
$72.0 p/Share
|
Feb 17
2021 |
NWBI
|
Mark T. Reitzes
SEVP, Commercial Banking |
BUY
Open market or private purchase
|
Indirect | 3,650 Added 21.47% |
$50,114
$13.73 p/Share
|
Feb 17
2021 |
BSRR
|
Laurence S Dutto
Director |
BUY
Open market or private purchase
|
Direct | 500 Added 9.86% |
$12,245
$24.49 p/Share
|
Feb 17
2021 |
CDAK
|
Briggs Morrison
Director |
BUY
Open market or private purchase
|
Direct | 4,761 Added 50.0% |
$99,981
$21.0 p/Share
|
Feb 17
2021 |
CRVS
|
Richard A Md Miller
President and CEO |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 7.25% |
$350,000
$3.5 p/Share
|
Feb 17
2021 |
SPLP
|
Gordon A. Walker
Senior Vice President |
BUY
Open market or private purchase
|
Indirect | 2,596 Added 9.15% |
$54,360
$20.94 p/Share
|
Feb 17
2021 |
BBIO
|
Brian C Stephenson
CFO and Treasurer |
BUY
Open market or private purchase
|
Direct | 8,000 Added 2.6% |
$500,000
$62.5 p/Share
|
Feb 17
2021 |
SCPS
|
Ira Scott Greenspan
Executive Committee Chairman |
BUY
Open market or private purchase
|
Indirect | 200 Added 6.9% |
$1,962
$9.81 p/Share
|
Feb 17
2021 |
SCPS
|
Ira Scott Greenspan
Executive Committee Chairman |
BUY
Open market or private purchase
|
Direct | 475 Added 0.59% |
$4,603
$9.69 p/Share
|
Feb 17
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 45 Added 0.31% |
$51,427
$1142.83 p/Share
|
Feb 17
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 5 Added 0.41% |
$5,714
$1142.83 p/Share
|
Feb 17
2021 |
ONCR
|
James E Flynn
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300,000 Added 8.7% |
$5,700,000
$19.0 p/Share
|
Feb 17
2021 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.21% |
$1,566
$2.32 p/Share
|
Feb 17
2021 |
BKI
|
John D Rood
Director |
BUY
Open market or private purchase
|
Direct | 3,000 Added 3.79% |
$241,680
$80.56 p/Share
|
Feb 17
2021 |
NUS
|
Daniel W Campbell
Director |
BUY
Open market or private purchase
|
Direct | 4,955 Added 5.78% |
$250,723
$50.6 p/Share
|
Feb 17
2021 |
NUS
|
Daniel W Campbell
Director |
BUY
Open market or private purchase
|
Indirect | 4,955 Added 50.0% |
$251,169
$50.69 p/Share
|
Feb 17
2021 |
NUS
|
Steven Lund
Exec. Chairman of the Board |
BUY
Open market or private purchase
|
Indirect | 20,850 Added 7.97% |
$1,001,842
$48.05 p/Share
|
Feb 17
2021 |
TWO
|
Matthew Koeppen |
BUY
Open market or private purchase
|
Direct | 20,000 Added 10.47% |
$133,200
$6.66 p/Share
|
Feb 17
2021 |
TWO
|
William Ross Greenberg
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 17,500 Added 9.2% |
$115,850
$6.62 p/Share
|
Feb 17
2021 |
BBIO
|
Randal W. Scott |
BUY
Open market or private purchase
|
Direct | 16,000 Added 43.24% |
$1,000,000
$62.5 p/Share
|
Feb 17
2021 |
STBA
|
Christine J Toretti
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 15.82% |
$56,000
$28.0 p/Share
|
Feb 17
2021 |
GCBC
|
Jay P. Cahalan
Director |
BUY
Open market or private purchase
|
Direct | 610 Added 5.2% |
$14,792
$24.25 p/Share
|
Feb 17
2021 |
BWFG
|
Penko Krassimir Ivanov
EVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 500 Added 29.78% |
$10,970
$21.94 p/Share
|
Feb 17
2021 |
EMCF
|
William C Marsh
Chairman, President & CEO |
BUY
Open market or private purchase
|
Direct | 1,200 Added 1.65% |
$30,936
$25.78 p/Share
|
Feb 17
2021 |
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 1.87% |
$1,496
$9.97 p/Share
|
Feb 17
2021 |
AVRO
|
Phillip B. Donenberg |
BUY
Open market or private purchase
|
Direct | 2,000 Added 50.0% |
$23,420
$11.71 p/Share
|
Feb 17
2021 |
TLIS
|
Baker Bros. Advisors LP
Director |
BUY
Open market or private purchase
|
Indirect | 6,250,000 Added 44.86% |
$100,000,000
$16.0 p/Share
|
Feb 17
2021 |
APLT
|
Alexandria Real Estate Equities, Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 43,478 Added 3.27% |
$999,994
$23.0 p/Share
|
Feb 17
2021 |
DBTX
|
Glaxosmithkline PLC
Director |
BUY
Open market or private purchase
|
Indirect | 150,000 Added 11.25% |
$2,700,000
$18.0 p/Share
|
Feb 17
2021 |
ATEX
|
Owl Creek Asset Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 28,300 Added 0.53% |
$1,184,355
$41.85 p/Share
|
Feb 17
2021 |
ATEX
|
Owl Creek Asset Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 122,817 Added 1.13% |
$5,286,044
$43.04 p/Share
|
Feb 17
2021 |
DBTX
|
Orbimed Advisors LLC
Director |
BUY
Open market or private purchase
|
Indirect | 1,666,666 Added 30.52% |
$29,999,988
$18.0 p/Share
|
Feb 17
2021 |
CRVS
|
Orbimed Advisors LLC
Director |
BUY
Open market or private purchase
|
Indirect | 1,285,714 Added 13.77% |
$4,499,999
$3.5 p/Share
|
Feb 17
2021 |
HIE
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,023 Added 0.16% |
$34,477
$8.57 p/Share
|
Feb 17
2021 |
MTD
|
Patrick Kaltenbach
President and CEO |
BUY
Open market or private purchase
|
Direct | 50 Added 3.8% |
$58,500
$1170.0 p/Share
|
Feb 17
2021 |
SLM
|
Mary Carter Warren Franke
Director |
BUY
Open market or private purchase
|
Indirect | 7,000 Added 50.0% |
$105,210
$15.03 p/Share
|
Feb 17
2021 |
BCAT
|
Russell Jared Koesterich |
BUY
Open market or private purchase
|
Direct | 3,000 Added 17.14% |
$65,880
$21.96 p/Share
|
Feb 17
2021 |
BITE-WT
|
Rafael Felipe De Jesus Aguirre Gomez
Director |
BUY
Open market or private purchase
|
Indirect | 470,000 Added 7.96% |
-
|
Feb 17
2021 |